Der Ophthalmologe

, Volume 111, Issue 1, pp 10–14 | Cite as

Vaskuläre Netzhauterkrankungen als Spiegel generalisierter Gefäßveränderungen

Was können wir voneinander lernen?
Leitthema

Zusammenfassung

Bei vaskulären retinalen Veränderungen ist die Augenerkrankung in den meisten Fällen eine Folge der systemischen Gefäßerkrankung. Häufig sind diese Systemerkrankungen bereits bekannt, in anderen Fällen werden sie erstmals durch die retinalen Veränderungen festgestellt. Patienten mit vaskulären Funduserkrankungen müssen meistens interdisziplinär betreut werden. Sowohl für den Ophthalmologen als auch für die mitbetreuenden Fachdisziplinen stellt sich im klinischen Alltag aber nicht selten die Frage, welche Untersuchungen erforderlich sind und welche Fachdisziplinen noch in die Abklärung der Risikofaktoren oder die Behandlung mit einbezogen werden müssen. In diesem Beitrag möchten wir einen Überblick über die wichtigsten vaskulären retinalen Erkrankungen und die nach Diagnosestellung erforderlichen Untersuchungen geben.

Schlüsselwörter

Systemerkrankungen Vaskuläre Funduserkrankungen Retinale Verschlusserkrankungen Systemische Gefäßerkrankung Verschlussereignis 

Retinal vascular diseases reflecting generalized vascular alterations

What can be mutually learnt?

Abstract

Retinal vascular diseases are mostly caused by systemic vascular diseases. In some cases the systemic disease is already known but in other patients ocular anomalies often provide the first indications of a systemic disease. Treating patients with vascular fundus diseases requires close cooperation between ophthalmologists and specialists in other fields and deciding which routine and specialized diagnostic examinations are necessary in light of the potential risk factors involved requires interdisciplinary communication. This article aims to provide an overview of the most important vascular retinal diseases and which examinations are required to ensure an accurate diagnosis. The retinal vascular diseases with the highest frequency or clinical relevance are hypertensive retinopathy, diabetic retinopathy, retinal vein occlusion and retinal artery occlusion.

Keywords

Systemic diseases Vascular fundus diseases Retinal obstructive diseases Systemic vascular diseases Occlusive event 

Literatur

  1. 1.
    Göbel W, Matlach J (2013) Hypertensive changes of the fundus. Ophthalmologe 110:995–1007PubMedCrossRefGoogle Scholar
  2. 2.
    Schnurrbusch U, Wolf S (2005) Fundus hypertonicus. Ocular changes with systematic illnesses. Ophthalmologe 3:301–312CrossRefGoogle Scholar
  3. 3.
    Wong TY, Mitchell P (2004) Hypertensive retinopathy. N Engl J Med 351:2310–2317PubMedCrossRefGoogle Scholar
  4. 4.
    Kearney PM, Whelton M, Reynolds K et al (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365:217–223PubMedGoogle Scholar
  5. 5.
    Wolf A, Kernt M, Kampik A, Neubauer AS (2010) Systemische kardiovaskulare Risikoabschatzung. Klassisch oder fundusbasiert? Ophthalmologe 107:814–820PubMedCrossRefGoogle Scholar
  6. 6.
    Wong T, Mitchell P (2007) The eye in hypertension. Lancet 369:425–435PubMedCrossRefGoogle Scholar
  7. 7.
    Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 31:1925–1938CrossRefGoogle Scholar
  8. 8.
    Hammes H-P, Lemmen K-D, Jochmann C, Wiedemann P (2006) Diabetic retinopathy and maculopathy. Dtsch Med Wochenschr 131:1173–1175PubMedCrossRefGoogle Scholar
  9. 9.
    Retinologische Gesellschaft, Deutsche Ophthalmologische Gesellschaft, Berufsverband der Augenärzte Deutschland (2011) Recommendation of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany: treatment of diabetic maculopathy. Klin Monatsbl Augenheilkd 228:446–459CrossRefGoogle Scholar
  10. 10.
    Klein BEK (2007) Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 14:179–183PubMedCrossRefGoogle Scholar
  11. 11.
    Gelisken F, Ziemssen F (2010) Diabetic maculopathy. Diagnosis and treatment. Ophthalmologe 107:773–786 (quiz 787–788)PubMedCrossRefGoogle Scholar
  12. 12.
    Hanefeld M, Schönauer M, Forst T (2010) Glycemic control and cardiovascular benefit: what do we know today? Dtsch Med Wochenschr 135:301–307PubMedCrossRefGoogle Scholar
  13. 13.
    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287:2563–2569CrossRefGoogle Scholar
  14. 14.
    Early Treatment Diabetic Retinopathy Study Research Group (1981) Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. TOphthalmology 88:583–600CrossRefGoogle Scholar
  15. 15.
    Early Treatment Diabetic Retinopathy Study Research Group (1995) Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Arch Ophthalmol 113:1144–1155CrossRefGoogle Scholar
  16. 16.
    Klein R, Klein BE, Moss SE et al (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102:520–526PubMedCrossRefGoogle Scholar
  17. 17.
    Klein R, Klein BE, Moss SE et al (1984) The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527–532PubMedCrossRefGoogle Scholar
  18. 18.
    United Kingdom Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703–713CrossRefGoogle Scholar
  19. 19.
    Hata J, Arima H, Rothwell PM et al (2013) Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the advance trial. Circulation 128:1325–1334PubMedCrossRefGoogle Scholar
  20. 20.
    Gaede P, Vedel P, Parving HH, Pedersen O (1999) Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 353:617–622PubMedCrossRefGoogle Scholar
  21. 21.
    Sjølie AK, Klein R, Porta M et al (2008) Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet 372:1385–1393PubMedCrossRefGoogle Scholar
  22. 22.
    Retinologische Gesellschaft, Deutsche Ophthalmologische Gesellschaft, Berufsverband der Augenärzte Deutschland (2010) Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augenärzte Deutschlands zur Therapie des Makulaödems beim retinalen Venenverschluss. Ophthalmologe 107:583–596CrossRefGoogle Scholar
  23. 23.
    Khan Z, Almeida DRP, Rahim K et al (2013) 10-year Framingham risk in patients with retinal vein occlusion: a systematic review and meta-analysis. Can J Ophthalmol 48:40–45.e1PubMedCrossRefGoogle Scholar
  24. 24.
    Bertelsen M, Linneberg A, Rosenberg T et al (2012) Comorbidity in patients with branch retinal vein occlusion: case-control study. BMJ 345:e7885PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Christiansen CB, Lip GY, Lamberts M et al (2013) Retinal vein and artery occlusions:a risk factor for stroke in atrial fibrillation. J Thromb Haemost 11(8):1485–1492PubMedCrossRefGoogle Scholar
  26. 26.
    Feltgen N, Schmidt D, Hansen L (2003) Arterielle retinale Verschlüsse. Ophthalmologe 100:651–665 (quiz 666–667)PubMedCrossRefGoogle Scholar
  27. 27.
    Heinz J (2010) Internal medical investigations for non-arteritic retinal artery occlusion. Ophthalmologe 107:806–813PubMedCrossRefGoogle Scholar
  28. 28.
    Lorentzen SE (1969) Occlusion of the central retinal artery. A follow-up. Acta Ophthalmol (Copenh) 47:690–703Google Scholar
  29. 29.
    Chang YS, Jan RL, Weng SF et al (2012) Retinal artery occlusion and the 3-year risk of stroke in taiwan: a nationwide population-based study. Am J Ophthalmol 154(4):645–652PubMedCrossRefGoogle Scholar
  30. 30.
    Petzold A, Islam N, Hu H-H, Plant GT (2013) Embolic and nonembolic transient monocular visual field loss: a clinicopathologic review. Surv Ophthalmol 58:42–62PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Universitäts AugenklinikGöttingenDeutschland
  2. 2.Praxis Zeitz Franko ZeitzDüsseldorfDeutschland

Personalised recommendations